|
OMIM |
Link |
Information gain |
01 |
|
F3
|
[NCBI]
|
0.00207495
|
|
|
scott syndrome
|
[NCBI]
|
0.00182279
|
|
|
TFPI
|
[NCBI]
|
0.000899326
|
|
|
GPS
|
[NCBI]
|
0.000694721
|
|
|
ATHS
|
[NCBI]
|
0.000683563
|
|
|
behcet syndrome
|
[NCBI]
|
0.000550055
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000377944
|
|
|
PF4
|
[NCBI]
|
0.000302589
|
|
|
CPB2
|
[NCBI]
|
0.000235139
|
|
|
von willebrand disease
|
[NCBI]
|
0.000196936
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000166847
|
|
|
PLG
|
[NCBI]
|
0.000161569
|
|
|
pechet factor deficiency
|
[NCBI]
|
0.000153137
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
0.000121215
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
9.2816e-05
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
9.2816e-05
|
|
|
CDG2A
|
[NCBI]
|
8.80934e-05
|
|
|
HFE4
|
[NCBI]
|
8.80934e-05
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
8.80934e-05
|
|
|
F2RL3
|
[NCBI]
|
8.74967e-05
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
8.42816e-05
|
|
|
factor xii deficiency
|
[NCBI]
|
7.59232e-05
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
7.18359e-05
|
|
|
CDG1A
|
[NCBI]
|
6.13732e-05
|
|
|
LAD
|
[NCBI]
|
5.79243e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
4.8297e-05
|
|
|
EGF
|
[NCBI]
|
4.80086e-05
|
|
|
NS1
|
[NCBI]
|
4.69263e-05
|
|
|
PCI
|
[NCBI]
|
3.97287e-05
|
|
|
complement component 6 deficiency
|
[NCBI]
|
3.66912e-05
|
|
|
PROCR
|
[NCBI]
|
3.0025e-05
|
|
|
F2
|
[NCBI]
|
2.94127e-05
|
|
|
HS3ST1
|
[NCBI]
|
2.91435e-05
|
|
|
ZNF385
|
[NCBI]
|
2.91435e-05
|
|
|
HRG
|
[NCBI]
|
2.54494e-05
|
|
|
GNA13
|
[NCBI]
|
2.44404e-05
|
|
|
ENTPD1
|
[NCBI]
|
2.26045e-05
|
|
|
F2RL2
|
[NCBI]
|
2.26045e-05
|
|
|
RAP1B
|
[NCBI]
|
2.18655e-05
|
|
|
CD151
|
[NCBI]
|
2.12096e-05
|
|
|
GAS6
|
[NCBI]
|
2.06203e-05
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
1.95955e-05
|
|
|
HABP2
|
[NCBI]
|
1.87252e-05
|
|
|
SLC2A1
|
[NCBI]
|
1.64271e-05
|
|
|
ITGB1
|
[NCBI]
|
1.64271e-05
|
|
|
F12
|
[NCBI]
|
1.61632e-05
|
|
|
SELP
|
[NCBI]
|
1.61632e-05
|
|
|
PLSCR1
|
[NCBI]
|
1.61632e-05
|
|
|
PTH
|
[NCBI]
|
1.49778e-05
|
|
|
INPP5D
|
[NCBI]
|
1.47961e-05
|
|
|
FMF
|
[NCBI]
|
1.46105e-05
|
|
|
MET
|
[NCBI]
|
1.4041e-05
|
|
|
GSN
|
[NCBI]
|
1.35354e-05
|
|
|
PAI1
|
[NCBI]
|
1.32225e-05
|
|
|
FN1
|
[NCBI]
|
1.30725e-05
|
|
|
factor x deficiency
|
[NCBI]
|
1.17645e-05
|
|
|
FGF23
|
[NCBI]
|
1.15372e-05
|
|
|
ITGB2
|
[NCBI]
|
1.10084e-05
|
|
|
A2M
|
[NCBI]
|
1.08109e-05
|
|
|
ITGB3
|
[NCBI]
|
1.02599e-05
|
|
|
KLK3
|
[NCBI]
|
1.02299e-05
|
|
|
VEGF
|
[NCBI]
|
1.01169e-05
|
|
|
PCNA
|
[NCBI]
|
9.64919e-06
|
|
|
F2R
|
[NCBI]
|
9.45561e-06
|
|
|
FGA
|
[NCBI]
|
9.23734e-06
|
|
|
factor v deficiency
|
[NCBI]
|
8.7625e-06
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
8.04258e-06
|
|
|
FGF1
|
[NCBI]
|
7.98719e-06
|
|
|
PTGS2
|
[NCBI]
|
7.71956e-06
|
|
|
RBP1
|
[NCBI]
|
7.04296e-06
|
|
|
IGFALS
|
[NCBI]
|
6.41525e-06
|
|
|
EGFR
|
[NCBI]
|
6.04618e-06
|
|
|
ALB
|
[NCBI]
|
5.96585e-06
|
|
|
CRH
|
[NCBI]
|
5.90023e-06
|
|
|
VIP
|
[NCBI]
|
5.67418e-06
|
|
|
VASP
|
[NCBI]
|
5.53705e-06
|
|
|
hemophilia a
|
[NCBI]
|
5.0039e-06
|
|
|
SST
|
[NCBI]
|
4.34432e-06
|
|
|
MPO
|
[NCBI]
|
3.95749e-06
|
|
|
XDH
|
[NCBI]
|
3.86751e-06
|
|
|
TNF
|
[NCBI]
|
3.61472e-06
|
|
|
SERPINA6
|
[NCBI]
|
3.14256e-06
|
|
|
PI
|
[NCBI]
|
2.68023e-06
|
|
|
INS
|
[NCBI]
|
2.14748e-06
|
|
|
EPO
|
[NCBI]
|
2.07791e-06
|
|
|
PPARA
|
[NCBI]
|
1.96594e-06
|
|
|
RA
|
[NCBI]
|
1.63993e-06
|
|
|
AVP
|
[NCBI]
|
1.01155e-06
|
|
|
SLE
|
[NCBI]
|
7.03499e-07
|
|
|
HGF
|
[NCBI]
|
4.02987e-07
|
|
|
CRC
|
[NCBI]
|
1.75962e-07
|
|
|
POMC
|
[NCBI]
|
7.27803e-08
|
|
|
GAPDH
|
[NCBI]
|
2.159e-08
|
|
|
AD
|
[NCBI]
|
7.39775e-09
|
|
|
SHBG
|
[NCBI]
|
2.35423e-09
|
|
|
APOB
|
[NCBI]
|
2.35993e-11
|
|